<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04703231</url>
  </required_header>
  <id_info>
    <org_study_id>20201987</org_study_id>
    <nct_id>NCT04703231</nct_id>
  </id_info>
  <brief_title>Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause</brief_title>
  <official_title>Comparison of Ocular Findings in Patients Between Surgical and Natural Menopause</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Batman Maternity and Child's Health Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Batman Maternity and Child's Health Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is aimed to compare the ocular findings in patients with natural and surgical menopause.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the parameters such as fundus examination, macular thickness, visual acuity and&#xD;
      lens opacities among female patients diagnosed with menopause between the ages of 40-65.The&#xD;
      criteria for exclusion from the study are the presence of a history of illness, drug use,&#xD;
      smoking and alcohol use.Inclusion criteria were female patients who were in menopause and who&#xD;
      did not use any medications. For surgical menopause, the uterus and ovaries were surgically&#xD;
      removed at least 3 months ago.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">April 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 23, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Macular thickness measurement</measure>
    <time_frame>3 months after menopause</time_frame>
    <description>Macular thickness(micron) in both eyes will be measured by optical coherence tomography,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Detecting lens opacities</measure>
    <time_frame>3 months after menopause</time_frame>
    <description>Lens opacities (Grade 1,2,3,4) will be measured by indirect biomicroscopy,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular pressure measurement</measure>
    <time_frame>3 months after menopause</time_frame>
    <description>Intraocular pressures( mm Hg) will be measured and recorded with the applanation tonometry device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparison of all detected data</measure>
    <time_frame>3 months after menopause</time_frame>
    <description>All numerical data will be analyzed and compared with relevant statistical tests and the p value will be accepted as less than 0.05 to be considered a statistically significant difference.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Menopause Surgical</condition>
  <condition>Macula Edema</condition>
  <condition>Visual Acuity Reduced Transiently</condition>
  <arm_group>
    <arm_group_label>Natural menopause(Control group)</arm_group_label>
    <description>Female patients between 45-60 years of age diagnosed with menopause without any intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical Menopause (Case group)</arm_group_label>
    <description>Female patients aged 45-60 years included in the study 3 months after bilateral oophorectomy and hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>measurement of macular thickness, corneal thickness and lens opacities</intervention_name>
    <description>The incidence of macular thickness, Corneal thickness, intraocular pressure and lens opacities will be investigated by an ophthalmologist.</description>
    <arm_group_label>Natural menopause(Control group)</arm_group_label>
    <arm_group_label>Surgical Menopause (Case group)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Will be studied in a patient population with low sociocultural level.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newly diagnosed menopause (Natural or Surgical Menopause( At least 3 months after&#xD;
             surgery),&#xD;
&#xD;
          -  No history of illness(Diabetes,Heart disease,Kidney disease etc.)&#xD;
&#xD;
          -  Not Smoking&#xD;
&#xD;
          -  Did not use alcohol&#xD;
&#xD;
          -  Have not use any medication&#xD;
&#xD;
          -  Age between 45-65 years&#xD;
&#xD;
          -  BMI between 20-25 kg/m&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smoking or Alchohol consumption&#xD;
&#xD;
          -  Age before 45 and after 65 years&#xD;
&#xD;
          -  Have chronic disease&#xD;
&#xD;
          -  Using any medication&#xD;
&#xD;
          -  Have not diagnosed Menopause&#xD;
&#xD;
          -  BMI greater than 30 kg/m&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Erhan Okuyan, M.D</last_name>
    <phone>+905336657313</phone>
    <email>dreo06@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Batman Maternity and Child Health Hospital</name>
      <address>
        <city>Batman</city>
        <zip>72000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erhan Okuyan, M.D</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 1, 2021</study_first_submitted>
  <study_first_submitted_qc>January 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 11, 2021</study_first_posted>
  <last_update_submitted>January 8, 2021</last_update_submitted>
  <last_update_submitted_qc>January 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Batman Maternity and Child's Health Hospital</investigator_affiliation>
    <investigator_full_name>Erhan Okuyan,M.D</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <keyword>menopause</keyword>
  <keyword>Eye disease</keyword>
  <keyword>Macular changes</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

